Metoclopramide Hydrochloride Bristol Laboratories

Metoclopramide Hydrochloride, the active ingredient in Metoclopramide Hydrochloride Bristol Laboratories, is a dopamine D2 receptor antagonist presented as an oral formulation for systemic use. It treats nausea, vomiting, gastroparesis and gastro‑oesophageal reflux disease in adult patients.

GNH USA supplies Metoclopramide Hydrochloride Bristol Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide Hydrochloride acts on the central chemoreceptor trigger zone and enhances gastrointestinal motility, making it useful for several gastrointestinal disorders.

- Nausea and vomiting: reduces episodes by blocking dopamine receptors in the chemoreceptor trigger zone. - Gastroparesis: accelerates gastric emptying through increased acetylcholine release in the gut. - Gastro‑oesophageal reflux disease (GERD): improves lower‑esophageal sphincter tone and gastric motility, helping to lessen reflux symptoms.

Metoclopramide Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness - Fatigue - Restlessness or akathisia - Diarrhoea - Constipation - Headache

Serious or Rare Side Effects: - Tardive dyskinesia (involuntary movements) - Neuroleptic malignant syndrome - Severe depression or suicidal thoughts - Seizures - Anaphylactic or severe allergic reactions - Hyperprolactinemia with galactorrhoea

Before prescribing Metoclopramide Hydrochloride, clinicians should consider several safety aspects.

- Pregnancy: safety not established; use only if benefits outweigh risks. - Breastfeeding: unknown excretion; consider alternative therapy. - Elderly patients: higher susceptibility to extrapyramidal symptoms; monitor closely. - Gastrointestinal obstruction: use with caution as pro‑kinetic effect may be limited. - Concomitant CNS depressants: may enhance sedation and respiratory depression. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Metoclopramide Hydrochloride can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticholinergic agents: may reduce the pro‑kinetic effect. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase plasma concentrations of metoclopramide. - Other dopamine antagonists: additive risk of extrapyramidal symptoms.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., alcohol, benzodiazepines): enhanced sedation. - MAO inhibitors: risk of hypertensive reactions.